Trimethoprim/sulfamethoxazole and moxifloxacin therapy for a pediatric stenotrophomonas maltophilia ventriculoperitoneal shunt infection

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Stenotrophomonas maltophilia is an increasingly prevalent cause of nosocomial infections. This report describes a 5-month-old male diagnosed with a S maltophilia ventriculoperitoneal shunt infection after a neurosurgical procedure. Intravenous trimethoprim/sulfamethoxazole and moxifloxacin successfully treated the patient. A literature review revealed a scarcity of similar reports, with none using moxifloxacin as an effective concomitant treatment with trimethoprim-sulfamethoxazole.

Cite

CITATION STYLE

APA

Gregory, E. R., Osborne, S. B., Gardner, B. M., & Broughton, R. A. (2019). Trimethoprim/sulfamethoxazole and moxifloxacin therapy for a pediatric stenotrophomonas maltophilia ventriculoperitoneal shunt infection. Journal of Pediatric Pharmacology and Therapeutics, 24(1), 61–65. https://doi.org/10.5863/1551-6776-24.1.61

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free